| Name | VPC-13789 |
|---|---|
| Synonyms | 5-Quinolinecboxamide, N-(1-methylethyl)-2-(5,6,7-trifluoro-1H-indol-3-yl) |
| Description | VPC-13789 is a potent, selective, and orally bioavailable antiandrogen. VPC-13789 can be used for the research of castration-resistant prostate cancer (CRPC) therapeutics. VPC-13789 inhibits androgen receptor (AR) transcriptional activity in LNCaP cells (IC50=0.19 μM)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C21H16F3N3O |
|---|---|
| Molecular Weight | 383.37 |